RT @GENbio
First Alzheimer's Disease #GeneSilencing Approach Lowers Tau Levels in Humans

Clinical trial results show promise for a new #genetic therapy for #Alzheimersdisease that lowers levels of the tau protein known to cause the disease. Learn more: http://ow.ly/Xv5L50NU7AE